B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells

Cancer Research

Volumn 69, Issue 9, 2009, Pages 4073-4080

  Mannefeld, Mirijam ^a   Klassen, Elena ^a   Gaubatz, Stefan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P130; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR B MYB; TRANSCRIPTION FACTOR E2F4; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER STAGING; CELL CYCLE G2 PHASE; CELL MUTANT; CONTROLLED STUDY; DISSOCIATION; DNA DAMAGE; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

EID: 65949108394     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4156     Document Type: Article

References (45)

1. Kastan MB. Bartek J. Cell-cycle checkpoints and cancer. Nature 2004; 432: 316-23.
2. Zhou BB. Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408: 433-9.
3. Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 2006; 31: 402-10.
4. el-Deiry WS. Tokino T. Velculescu VE. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-25.
5. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A 1995; 92: 8493-7.
6. 2-M by p53. Oncogene 1995; 10: 109-15.
7. 2 arrest after DNA damage. Science 1998; 282: 1497-501.
8. Taylor WR. Stark GR. Regulation of the G2-M transition by p53. Oncogene 2001; 20: 1803-15.
9. 2 arrest in response to overexpression of p53. Mol Biol Cell 1999; 10: 3607-22.
10. 2 checkpoint through cyclin B1. Proc Natl Acad Sci U S A 1999; 96: 2147-52.
11. Passalaris TM. Benanti JA. Gewin L. Kiyono T. Galloway DA. The G (2) checkpoint is maintained by redundant pathways. Mol Cell Biol 1999; 19: 5872-81.
12. Yun J. Chae HD. Choy HE. et al. p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J Biol Chem 1999; 274: 29677-82.
13. 2-M promoters. Mol Cell Biol 2005; 25: 3737-51.
14. Badie C. Itzhaki JE. Sullivan MJ. Carpenter AJ. Porter AC. Repression of CDK1 and other genes with CDE and CHRpromoter elements during DNA damage-induced G (2)/M arrest in human cells. Mol Cell Biol 2000; 20: 2358-66.
15. Krause K. Wasner M. Reinhard W. et al. The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res 2000; 28: 4410-8.
16. 2 arrest. J Biol Chem 2001; 276: 5570-6.
17. Riley T. Sontag E. Chen P. Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9: 402-12.
18. Lohr K. Moritz C. Contente A. Dobbelstein M. p21/CDKN1A mediates negative regulation of transcription by p53. J Biol Chem 2003; 278: 32507-16.
19. 2. J Cell Sci 2005; 118: 1821-32.
20. Jackson JG. Pereira-Smith OM. Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol Cell Biol 2006; 26: 2501-10.
21. Taylor WR. Schonthal AH. Galante J. Stark GR. p130/E2F4 binds to and represses the cdc2 promoter in response to p53. J Biol Chem 2001; 276: 1998-2006.
22. 2 arrest and down-regulation of Stathmin and AIM-1 expression in response to genotoxic stress. J Biol Chem 2003; 278: 1443-9.
23. Litovchick L. Sadasivam S. Florens L. et al. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 2007; 26: 539-51.
24. 2-M genes and for entry into mitosis. EMBO J 2007; 26: 144-57.
25. 2-M genes. Cell Cycle 2007; 6: 1903-13.
26. Pilkinton M. Sandoval R. Colamonici OR. Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phasedependent context distinct from the Drosophila dREAM complex. Oncogene 2007; 26: 7535-43.
27. Gagrica S. Hauser S. Kolfschoten I. Osterloh L. Agami R. Gaubatz S. Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-associated protein. EMBO J 2004; 23: 4627-38.
28. Miller LD. Smeds J. George J. et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 2005; 102: 13550-5.
29. Ivshina AV. George J. Senko O. et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 2006; 66: 10292-301.
30. Sorlie T. Perou CM. Tibshirani R. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10869-74.
31. Rhodes DR. Yu J. Shanker K. et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004; 6: 1-6.
32. Waldman T. Kinzler KW. Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995; 55: 5187-90.
33. Amatschek S. Koenig U. Auer H. et al. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res 2004; 64: 844-56.
34. Bertucci F. Houlgatte R. Benziane A. et al. Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 2000; 9: 2981-91.
35. Sotiriou C. Neo SY. McShane LM. et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003; 100: 10393-8.
36. Lauss M. Kriegner A. Vierlinger K. et al. Consensus genes of the literature to predict breast cancer recurrence. Breast Cancer Res Treat 2008; 110: 235-44.
37. Paik S. Shak S. Tang G. et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004; 351: 2817-26.
38. Yamauchi T. Ishidao T. Nomura T. et al. A B-Myb complex containing clathrin and filamin is required for mitotic spindle function. EMBO J 2008; 27: 1852-62.
39. 2 delay in HeLa cells. Cancer Res 1997; 57: 753-8.
40. Ianzini F. Mackey MA. Spontaneous premature chromosome condensation and mitotic catastrophe following irradiation of HeLa S3 cells. Int J Radiat Biol 1997; 72: 409-21.
41. Macurek L. Lindqvist A. Lim D. et al. Polo-like kinase- 1 is activated by aurora A to promote checkpoint recovery. Nature 2008; 455: 119-23.
42. 2 DNA damage-induced arrest in mammalian cells. Mol Cell 2004; 15: 799-811.
43. Ahlbory D. Appl H. Lang D. Klempnauer KH. Disruption of B-myb in DT40 cells reveals novel function for B-Myb in the response to DNA-damage. Oncogene 2005; 24: 7127-34.
44. Sonoda E. Sasaki MS. Buerstedde JM. et al. Rad51- deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J 1998; 17: 598-608.
45. Sala A. B-MYB. a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Eur J Cancer 2005; 41: 2479-84.